Current review of hemp‐based medicines in dogs-Reference-Cited by-同舟云学术

Current review of hemp‐based medicines in dogs

Published:2021-10-03 Issue:6 Volume:44 Page:870-882
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:J Vet Pharmacol Therap

Author:

R. C. Coelho Maria Paula¹^ORCID,de O. P. Leme Fabiola¹,A. Moreira Fabricio²,E. M. T. Branco Stephanie¹,M. Melo Marilia¹,G. de Melo Eliane¹

Affiliation:

1. Departamento de Clínica e Cirurgia Veterinárias Escola de Veterinária Universidade Federal de Minas Gerais Belo Horizonte Brazil

2. Departamento de Farmacologia Instituto de Ciências BiológicasUniversidade Federal de Minas Gerais Belo Horizonte Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvp.13016

Reference118 articles.

1. Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis;Abramo F.;BMC Veterinary Research,2014

2. The effects of cannabinoids on the brain

3. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review;Veterinary Research Communications;2024-08-20

2. Determinants of behavior towards hemp-based products: an application of the theory of planned behavior;British Food Journal;2024-07-01

3. Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs;Frontiers in Veterinary Science;2024-04-25

4. Canine Atopic Dermatitis: Systemic Indicators of Cannabis Therapy;ACTA SCI VET;2024

5. Exploring the untapped potential of cannabis in veterinary pharmacology, medicine, and beyond;Cannabis and Derivatives;2024